Brief: Crown Laboratories And Revance Amend A&R Merger Agreement
21/01/2025 13:43
Jan 21 (Reuters) - Revance Therapeutics Inc RVNC.O :
* CROWN LABORATORIES AND REVANCE AMEND THE A&R MERGER
AGREEMENT TO
INCREASE OFFER PRICE TO $3.65 PER SHARE AND EXTEND EXISTING
TENDER OFFER
* INCREASED OFFER PRICE TO $3.65 PER SHARE, A $0.55 PER
SHARE
INCREASE
* CROWN EXTENDS TENDER OFFER UNTIL FEBRUARY 4, 2025
Source text: ID:nBwbLQkd0a
Further company coverage: RVNC.O
Recent news on Revance Therapeutics
See all newsBrief: Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Brief: Crown Laboratories And Revance Amend A&R Merger Agreement
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Kratos, Forward Air, Bank stocks
U.S. STOCKS ON THE MOVE-Henry Schein, natgas firms, Citigroup